UNSPSC 85641783: Supplement of left lower arm subcutaneous tissue and fascia with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement of left lower arm subcutaneous tissue and fascia with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JUH07Z

UNSPSC 85641783 Supplement of left lower arm subcutaneous tissue and fascia with autologous tissue substitute, open approach is a Commodity code that shows minimal alignment with state and local government procurement activity. The recent solicitations tagged to this code address occupational medical surveillance, independent disability medical evaluations, pharmacy benefit management, Centers of Excellence carve-out networks for surgical procedures, temporary health professional staffing, and emergency medical services for detained youth — none of which involve surgical tissue supplementation or orthopedic reconstruction work. The mismatch suggests either mis-tagging by the sourcing jurisdictions or that this code does not represent a meaningful state and local procurement category in practice.

The recent opportunities span Arizona (Phoenix Fire and Police Pension Boards' disability evaluation services via RFP through October 16, 2026), California (City of Long Beach surgical benefits network, County of Santa Clara temporary health staffing), Washington State (Department of Transportation occupational surveillance), Texas (Harris County Juvenile Probation Department emergency medical services), and Florida (Collier County pharmacy benefit management), indicating nationwide issuing bodies that include city retirement offices, county health systems, and state transportation agencies. No pattern of repeat buyers or concentrated geographic activity emerges from the sample, and the opportunities represent administrative medical services procurement rather than tissue-engineering or surgical implant supply. Given the absence of relevant recent solicitations and the clear divergence between the code's nominal scope and what these jurisdictions are actually buying, this code warrants a skip decision for firms pursuing orthopedic or reconstructive implant markets in state and local procurement.